menu search

Catalyst pharmaceuticals to report third quarter 2023 financial results on november 8, 2023

The Company to Host a Conference Call and Webcast on November 9, 2023, at 8:30 AM ET CORAL GABLES, Fla., Oct. 23, 2023 (GLOBE NEWSWIRE) — Catalyst <...

October 23, 2023, 12:03 pm

What makes crinetics pharmaceuticals, inc. (crnx) a good fit for 'trend investing'

Crinetics pharmaceuticals, Inc. (CRNX) made it through our "Recent Price Strength" screen and could be ...

October 23, 2023, 10:34 am

Why is xortx therapeutics (xrtx) stock down 27% today?

Xortx Therapeutics (NASDAQ: XRTX ) stock is sliding lower on Monday as the pharmaceutical company's sh...

October 23, 2023, 9:10 am

Catalyst pharmaceuticals to report third quarter 2023 financial results on november 8, 2023

The Company to Host a Conference Call and Webcast on November 9, 2023, at 8:30 AM ET The Company to Host a Conference Call and Webcast on November 9, ...

October 23, 2023, 8:03 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...

October 23, 2023, 5:00 am

Merck discontinues some cancer drug development with china's sichuan kelun

Chinese drugmaker Sichuan Kelun pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the...

October 23, 2023, 3:47 am

Mallinckrodt to present data on terlivaz® (terlipressin) for injection in adult patients with hepatorenal syndrome (hrs) at the american college of gastroenterology (acg) annual scientific meeting

– Findings from two clinical studies and one health economic database analysis provide insight into HRS treatment outcomes with TERLIVAZ,1 patients'...

October 22, 2023, 3:05 pm

Eli lilly, novo nordisk to test weight loss drugs for children

pharmaceutical manufacturers Eli Lilly (LLY) and Novo Nordisk (NVO) are reportedly planning to test the...

October 22, 2023, 11:00 am

Bristol-myers squibb acquisition of mirati makes sense

Bristol Myers Squibb is a large pharmaceutical company with a strong dividend yield and impressive asse...

October 22, 2023, 8:53 am

Libtayo® (cemiplimab) neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma (cscc)

89% estimated event-free survival at one year among patients with stage II to IV resectable CSCC who received Libtayo prior to surgery in a Phase 2 tr...

October 21, 2023, 12:48 pm

Bristol-myers squibb: time to get greedy

Buying Bristol-Myers now could be a practical application of Buffett's advice to be greedy when others are fearful. As it stands right now, the ...

October 21, 2023, 10:24 am

Dmk pharmaceuticals announces inducement option grant under nasdaq listing rule 5635(c)(4)

SAN DIEGO, Oct. 20, 2023 (GLOBE NEWSWIRE) — DMK pharmaceuticals Corporation (NASDAQ: DMK), a commerci...

October 20, 2023, 8:15 pm

Ligand pharmaceuticals (lgnd) sees a more significant dip than broader market: some facts to know

In the closing of the recent trading day, Ligand pharmaceuticals (LGND) stood at $52.09, denoting a -1....

October 20, 2023, 7:33 pm

Ani pharmaceuticals (anip) increases despite market slip: here's what you need to know

ANI pharmaceuticals (ANIP) closed at $57.44 in the latest trading session, marking a +0.23% move from t...

October 20, 2023, 7:33 pm

Trending tickers: at&t, merck-daiichi sankyo, klaviyo: trending tickers october 29, 2023

Scotiabank analysts upgrade AT&T (T) stock from "Sector Perform" to "Sector Outperform." Merck (MRK) strikes a deal worth up to $22 billion with Japan...

October 20, 2023, 5:44 pm

Pharma firms testing weight loss drugs for kids amid ozempic craze

Get ready for Ozem-kids! The pharmaceutical companies behind Ozempic, Mounjaro and Wegovy — which hav...

October 20, 2023, 5:12 pm


Search within

Pages Search Results: